Walden Biosciences

About:

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.

Website: https://www.waldenbiosciences.com/

Twitter/X: WaldenBio

Top Investors: ARCH Venture Partners, Mass General Brigham Ventures, ATEM Capital Fund LP, UCB Ventures

Description:

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the pathology and biology of kidney disease.

Total Funding Amount:

$51M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)waldenbiosciences.com

Founders:

Ari Nowacek, Jochen Reiser, Sanja Sever

Number of Employees:

11-50

Last Funding Date:

2023-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai